The cost of a throat cancer operation in Spain typically ranges from $22,500 to $34,000. Prices can vary depending on the hospital, the surgeon’s experience, the complexity of the tumor removal, and whether reconstructive surgery is needed. In the United States, the average price is $120,000 (per American Cancer Society). This means throat cancer surgery in Spain is about 76% less than in the U.S.
Spanish hospitals generally include preoperative diagnostics, surgery, anesthesia, hospital stay, postoperative care, and follow-up visits in their packages. In the U.S., the base price often covers only the surgeon and hospital fees, with separate charges for anesthesia, pathology, and follow-up care. Patients should confirm exactly what’s included at each clinic before making a decision.
Why choose Spain for throat cancer operation?
Access advanced Throat cancer operation solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Throat cancer operation | from $9,000 | from $30,000 | from $22,500 |
| Tongue cancer surgery | from $9,000 | from $35,000 | from $18,000 |
| Laser surgery for laryngeal cancer | from $7,000 | from $15,000 | from $12,000 |
| Intervention to laryngeal polyps with endolaryngeal microsurgery | from $2,390 | from $3,500 | from $3,800 |
| Laryngectomy | from $8,000 | from $25,000 | from $18,000 |
Medically reviewed by
Fahad MawloodDay 1 - Arrival
Day 2 - Pre-operation
Day 3 - Operation Day
Day 4 - Post-operation
Day 5 to Day 10 - Hospital Stay
Week 2 to Week 6 - Rehabilitation
Each patient"s recovery process will differ based on individual health conditions and the extent of the disease.
Dr. Xavier Centeno Fornies brings over 30 years of surgical expertise, including specialized training at the Mayo Clinic. He currently leads the surgery department at Centro Médico Teknon.
Dr. Luis Madero is a pediatric oncologist with 37 years of experience in treating blood disorders, bone marrow transplant, ablation therapy, and other diseases. He is a member of several associations and has extensive experience in his field.
Dr. Enriqueta Felip is an expert in thoracic oncology. She specializes in lung cancer care and clinical trials. She earned her medical degree and PhD from UAB. Dr. Felip has led research on improving chemotherapy, developing new therapies, using immunotherapy, and understanding resistance to targeted treatments.
She served as a board member of the IASLC from 2017 to 2021 and was Vice-President of SEOM from 2019 to 2021. In 2015, she received the first ESMO Women for Oncology Award. Dr. Felip has written many peer-reviewed articles and book chapters. She is known for her leadership in international oncology societies and clinical research.